drug summary · 2 NDC codes
Orladeyo 132 mg/1
Berotralstat hydrochloride
HUMAN PRESCRIPTION DRUG record from the RxAtlas dataset, marketing status NDA. Facts and NDC codes below are exported values from the current release, not inferred or edited prose.
Facts
Field definitions, types, and provenance rules are in the data dictionary.
| generic name | Berotralstat hydrochloride |
|---|---|
| active ingredients | BEROTRALSTAT HYDROCHLORIDE |
| dosage form | PELLET |
| route | ORAL |
| strength | 132 mg/1 |
| marketing status | NDA |
| DEA schedule | not reported |
| application number | NDA219776 |
| ATC code | not reported |
| RxCUI | not reported |
| manufacturer | BioCryst Pharmaceuticals, Inc. |
| product type | HUMAN PRESCRIPTION DRUG |
| pharmacologic class | Cytochrome P450 2D6 Inhibitors [MoA]; Cytochrome P450 3A4 Inhibitors [MoA]; Kallikrein Inhibitors [MoA]; P-Glycoprotein Inhibitors [MoA]; Plasma Kallikrein Inhibitor [EPC] |
NDC codes
2 National Drug Codes are mapped to this product in the current release. Package descriptions are not part of the published export, so the NDC code is the canonical package identifier here.
| NDC | Package description |
|---|---|
| 72769-114 | — |
| 72769011402 | — |
Other Berotralstat hydrochloride products
5 other products in the current release publish the same generic name. Strength, dosage form, and labeler are what distinguish them.
- Orladeyo 108 mg/1PELLET · BioCryst Pharmaceuticals, Inc.
- Orladeyo 110 mg/1CAPSULE · BioCryst Pharmaceuticals, Inc.
- Orladeyo 150 mg/1CAPSULE · BioCryst Pharmaceuticals, Inc.
- Orladeyo 72 mg/1PELLET · BioCryst Pharmaceuticals, Inc.
- Orladeyo 96 mg/1PELLET · BioCryst Pharmaceuticals, Inc.
Work with this record
- Field definitions
Types, scope, and provenance rules for every exported field.
- REST API
Query the same gate-backed records programmatically.
- Evaluation sample
Download a bounded slice before buying.
- $29 API Pass
Seven days of REST and MCP access to the full catalogue; credited toward the licence.